Carrà Giuseppe, Bartoli Francesco, Brambilla Giulia, Crocamo Cristina, Clerici Massimo
a Division of Psychiatry, Faculty of Brain Sciences , University College London , London , UK.
Subst Abus. 2015;36(1):75-81. doi: 10.1080/08897077.2014.960551. Epub 2014 Sep 15.
Most evidence about comorbid addiction and major mental illness comes from the USA, since this literature remains relatively limited in many European countries. The purpose of this review was to examine prevalence, policies, and treatment systems of comorbid substance misuse and psychotic illness in Europe, illustrating differences and similarities with US findings.
Based on computerized main databases searches, a narrative review was performed.
The availability of substances but also the social contexts in terms of individual and local issues are factors likely to explain different dual diagnosis prevalence rates in Europe as compared with the USA.
Integrated models implemented following US example might perform differently within the context of well-established European Union (EU) community mental health services. Such programs would require additional resources and radical redesign of service delivery systems.
关于成瘾合并症与重度精神疾病的大多数证据来自美国，因为在许多欧洲国家，这方面的文献仍然相对有限。本综述的目的是研究欧洲物质滥用与精神病性疾病合并症的患病率、政策和治疗体系，阐明与美国研究结果的异同。
基于计算机化的主要数据库检索，进行了一项叙述性综述。
与美国相比，物质的可获得性以及个人和当地问题方面的社会背景可能是解释欧洲不同双重诊断患病率的因素。
效仿美国实施的综合模式在成熟的欧盟社区精神卫生服务背景下可能会有不同表现。此类项目将需要额外资源，并对服务提供系统进行彻底重新设计。
